Health researchMon 2 Nov 2026 · 6 of 13

Single Blood Protein Identified as Top Marker for Fatty Liver Disease

Verified · 7/7 supported1 cited · 1 min read

Medical Xpress reports that a single blood protein stands out among 30 tests for assessing fatty liver disease . Medical Xpress reports that accurate assessment of metabolic dysfunction‑associated steatotic liver disease (MASLD) is essential for staging, treatment decisions, and therapy monitoring . Medical Xpress reports that liver biopsy has traditionally been required to diagnose and stage MASLD . Medical Xpress reports that new blood tests could provide a non‑invasive, inexpensive way to evaluate liver health in the general population . Medical Xpress reports that the LITMUS study compared 30 biomarkers and combinations to diagnose MASLD and its advanced stage, metabolic dysfunction‑associated steatohepatitis (MASH) . Medical Xpress reports that the study analyzed data from 1,590 MASLD patients who had been diagnosed via tissue biopsy .

Why it matters. Medical Xpress notes that this could enable broader, non‑invasive screening for liver health in the general population .

Earlier on Health research

Sun 1 Nov 2026Blocking TET2 May Reverse Radiation-Induced Immune Suppression in CancerMedical Xpress reports that researchers at the University of Chicago identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them. Medical Xpress reports that radiation activates the protein TET2 on bone‑marrow immune cells, removing chemical tags from RNA and locking them into an immune‑suppressing state. Medical Xpress reports that blocking TET2 causes these immune cells to fight cancer, enhancing the effectiveness of radiation and immunotherapy to shrink tumors and control metastasis. Medical Xpress reports that radiation therapy is administered to 50%–60% of cancer patients and kills tumor cells by damaging DNA. Medical Xpress reports that radiation can trigger the expansion of myeloid‑derived suppressor cells (MDSCs), which travel to tumors and block CD8⁺ T cells, the primary tumor‑killing immune cells.Sat 31 Oct 2026FDA grants accelerated approval for first plasmid DNA immunotherapy, Voceryq, for adult RRPThe U.S. Food and Drug Administration granted accelerated approval for Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid‑gxfd) to treat adults with recurrent respiratory papillomatosis (RRP). Voceryq is the first plasmid DNA‑based immunotherapy approved in the United States. RRP is a rare disease caused by human papillomavirus that produces wart‑like growths in the airways. Clinical data showed Voceryq reduces the burden of surgical intervention for RRP patients.Fri 30 Oct 2026Study Finds Fruit and Veggie Scraps Are Rich in Dietary FiberMedical Xpress reports that most people routinely discard the peels, skins, stalks and seeds of fruits and vegetables at mealtime. Medical Xpress reports that new research from King's College London suggests these discarded parts could be a valuable source of dietary fiber, offering potential health and environmental benefits. Medical Xpress reports that the study, published in the International Journal of Food Sciences and Nutrition, analyzed 12 common types of fresh produce in the U.K.. Medical Xpress reports that in 10 out of 12 cases, the 'root-to-tip' components such as peels, skins and stalks contained significantly higher levels of dietary fiber than the portions normally eaten. Medical Xpress reports that only 4% of British adults meet the recommended minimum daily intake of 30 g of dietary fiber, highlighting a public health shortfall alongside a food‑waste crisis.
Next · Formula 1Piastri penalised after Turn 1 collision at Mexico City Grand Prix →